Abstract Search

ea0081ep1080 | Thyroid | ECE2022

Neutropenia in hyperthyroidism

Elias Ortega Cristina , Zunzunegui Nerea Egan a , Delgado Cristina Garcia , Calafell Maria Teresa Aramburu , Alvaro Jorge Rojo , Nebreda Inmaculada Venegas , Achucarro Ane Amilibia , Garay Ismene Bilbao , Arrieta Alfredo Yoldi

Introduction: Neutropenia can indicate infectious and hematological pathology but it can also be a sign of hyperthyroidism. For this reason, it has been suggested to perform a complete blood count before starting treatment with antithyroid drugs in case of new-onset hyperthyroidism. Antithyroid drugs can cause severe neutropenia, also called agranulocytosis, when the neutrophil count is less than 500/µl. Therefore, the use of these drugs should be reconsidered if it is le...

0 shares

ea0073aep160 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Could we use SGLT2 inhibitors without serious concern in the elderly?

Ihintza Larrañaga , Vives Cristina Goena , Maria Magdalena Arteaga Ossa , Alvaro Jorge Rojo , Laura Mañas Alonso , Ovejero Laura Quintas , Begoña Maíz Alcorta , Rodrigo Ana Moreno , Nerea Andrés Imaz , Irene Larrañaga Gomez , Villar Ruth Agirrezabalaga , Abasolo Amaia Aspiazu , Suarez Teresa Arana , Dadebat Naroa Rico , Amaia Cristina Armentia Del Pozo , Irizar Sara Diez , Tijero Naroa Gomez , Jose Francisco Egido Arroyo

BackgroundTherapeutic experience with SGLT2i is limited in the elderly. Its initiation is not recommended in patients over 85 years based on volume depletion risk. The aim of this study is to analyze clinical efficacy and safety of SGLT2i in elder T2DM patients.MethodsThis observational retrospective study included 544 T2DM subjects who initiated SGLT2i as add-on treatment between February 20182019 and ...

0 shares

Endocrine Abstracts

Neutropenia in hyperthyroidism

Could we use SGLT2 inhibitors without serious concern in the elderly?

BiosciAbstracts